“Startups usually launch their products first in wealthy countries. Launching first in an emerging market is seen as a nonstarter because of commercial, regulatory, and political risks. This is starting to change: Pricewaterhousecoopers recently reported that faster approvals overseas are encouraging startups to enter the U.S. market last in some cases.
Consider Diagnostics for All, a Boston-area startup developing paper-based diagnostic tests the size of a postage stamp. Miniature wells patterned onto the paper contain chemicals that react with samples of blood, urine, saliva, or sweat, which causes the paper to display a reading with a change of color.
The technology is revolutionary because the paper tests can be manufactured for only a few cents and can deliver test results instantaneously. By contrast, existing diagnostic machines sold by multinationals cost over $20 per test and $30,000 for the test reader, require trained technicians, and take three hours to yield results. Even in wealthy countries, community hospitals and rural clinics can’t afford them. . .” Full Story on Harvard Business Review
Founded in 2007, Ladybrille® Magazine is a California based pioneer digital publication demystifying the image of Africans in the west through contemporary African fashion and celebrating the brilliant woman in business and leadership, with an emphasis on the African woman in the diaspora. Our coverage includes stories on capital, access to markets, expertise, hiring and retention, sales, marketing, and promotions.